Effect of Puberty Onset on Spontaneous Hepatitis B Virus e Antigen Seroconversion in Men

Gastroenterology

Volumn 138, Issue 3, 2010, Pages

  Wu, Jia Feng ^a   Tsai, Wen Yu ^a   Hsu, Hong Yuan ^a   Ni, Yen Hsuan ^a   Chen, Huey Ling ^a   Tsuei, Daw Jen ^a   Chang, Mei Hwei ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Hepatitis B Virus e Antigen; Puberty; Steroid 5 Reductase Type II; Testosterone

Indexed keywords

ALANINE AMINOTRANSFERASE; ANDROGEN RECEPTOR; HEPATITIS E ANTIGEN; STEROID 5ALPHA REDUCTASE 2;

ADOLESCENT; ADULTHOOD; ALLELE; ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DNA POLYMORPHISM; EXON; FOLLOW UP; GENOTYPE; HEPATITIS B; HUMAN; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; PUBERTY; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SEROCONVERSION; TESTOSTERONE BLOOD LEVEL; VIRUS LOAD;

EID: 77249167734     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2009.11.051     Document Type: Article

References (29)

1. Beasley R.P., Hwang L.Y., Lin C.C., et al. Hepatocellular carcinoma and hepatitis B virus: a prospective study of 22,707 men in Taiwan. Lancet 2 (1981) 1129-1133
2. Liu Z., Luo K., He H., et al. Hot-spot mutations in hepatitis B virus core gene: eliciting or evading immune clearance?. J Viral Hepat 12 (2005) 146-153
3. Fattovich G., Rugge M., Brollo L., et al. Clinical, virologic, and histologic outcome following seroconversion from HBeAg to anti-HBe in chronic hepatitis type B. Hepatology 6 (1986) 167-172
4. Yang H.I., Lu S.N., Liaw Y.F., et al. Hepatitis B e antigen and the risk of hepatocellular carcinoma. N Engl J Med 347 (2002) 168-174
5. Ni Y.H., Chang M.H., Chen P.J., et al. Viremia profiles in children with chronic hepatitis B virus infection and spontaneous e antigen seroconversion. Gastroenterology 132 (2007) 2340-2345
6. Beasley R.P., Trepo C., Stevens C.E., et al. The e antigen and vertical transmission of hepatitis B surface antigen. Am J Epidemiol 105 (1977) 94-98
7. Hsu S.C., Chang M.H., Ni Y.H., et al. Horizontal transmission of hepatitis B virus in children. J Pediatr Gastroenterol Nutr 16 (1993) 66-69
8. Hsu H.Y., Chang M.H., Chen D.S., et al. Baseline seroepidemiology of hepatitis B virus infection in children in Taipei, 1984: a study just before mass hepatitis B vaccination program in Taiwan. J Med Virol 18 (1986) 301-307
9. Chang M.H., Sung J.L., Lee C.Y., et al. Factors affecting clearance of hepatitis B e antigen in hepatitis B surface antigen carrier children. J Pediatr 115 (1989) 385-390
10. Shiratori Y., Shiina S., Imamura M., et al. Characteristic difference of hepatocellular carcinoma between hepatitis B- and C-viral infection in Japan. Hepatology 22 (1995) 1027-1033
11. Lee C.M., Lu S.N., Changchien C.S., et al. Age, gender, and local geographic variations of viral etiology of hepatocellular carcinoma in a hyperendemic area for hepatitis B virus infection. Cancer 86 (1999) 1143-1150
12. Evans A.A., Chen G., Ross E.A., et al. Eight-year follow-up of the 90,000-person Haimen city cohort: I. hepatocellular carcinoma mortality, risk factors, and gender differences. Cancer Epidemiol Biomarkers Prev 11 (2002) 369-376
13. Chang M.H., Shau W.Y., Chen C.J., et al. Hepatitis B vaccination and hepatocellular carcinoma rates in boys and girls. JAMA 284 (2000) 3040-3042
14. Taylor B.C., Yuan J.M., Shamliyan T.A., et al. Clinical outcomes in adults with chronic hepatitis B in association with patients and viral characteristics: a systemic review of evidence. Hepatology 49 (2009) S85-S95
15. Yu M.W., Cheng S.W., Lin M.W., et al. Androgen-receptor gene CAG repeats, plasma testosterone levels, and risk of hepatitis B-related hepatocellular carcinoma. J Natl Cancer Inst 92 (2000) 2023-2028
16. Yeh S.H., Chiu C.M., Chen C.L., et al. Somatic mutations at the trinucleotide repeats of androgen receptor gene in male hepatocellular carcinoma. Int J Cancer 120 (2007) 1610-1617
17. Paz-y-Mino C., Witte T., Robles P., et al. Association among polymorphisms in the steroid 5alpha-reductase type II (SRD5A2) gene, prostate cancer risk, and pathologic characteristics of prostate tumors in an Ecuadorian population. Cancer Genet Cytogenet 189 (2009) 71-76
18. Yu M.W., Yang Y.C., Yang S.Y., et al. Hormonal markers and hepatitis B virus-related hepatocellular carcinoma risk: a nested case-control study among men. J Natl Cancer Inst 93 (2001) 1644-1651
19. Beilin J., Ball E.M., Favaloro J.M., et al. Effect of the androgen receptor CAG repeat polymorphism on transcriptional activity: specificity in prostate and non-prostate cell lines. J Mol Endocrinol 25 (2000) 85-96
20. Mhatre A.N., Trifiro M.A., Kaufman M., et al. Reduced transcriptional regulatory competence of the androgen receptor in X-linked spinal and bulbar muscular dystrophy. Nat Genet 5 (1993) 184-188
21. Makridakis N., Ross R.K., Pike M.C., et al. A prevalent missense substitution that modulates activity of prostate steroid 5α reductase. Cancer Res 57 (1997) 1020-1022
22. Gray A., Feldman H.A., McKinlay J.B., et al. An examination of research design effects on the association of testosterone and male aging: results of a meta-analysis. J Clin Epidemiol 44 (1991) 671-684
23. Gapstur S.M., Gann P.H., Kopp P., et al. Serum androgen concentrations in young men: a longitudinal analysis of associations with age, obesity, and race. The CARDIA male hormone study. Cancer Epidemiol Biomarkers Prev 11 (2002) 1041-1047
24. Yeh S.H., Tsai C.Y., Kao J.H., et al. Quantification and genotyping of hepatitis B virus in a single reaction by real-time PCR and melting curve analysis. J Hepatol 41 (2004) 659-666
25. Giovannucci E., Stampfer M.J., Krithivas K., et al. The CAG repeat within the androgen receptor gene and its relationship to prostate cancer. Proc Natl Acad Sci U S A 94 (1997) 3320-3323
26. Wu J.F., Chen C.H., Hsieh R.P., et al. HLA typing associated with hepatitis B e antigen seroconversion in children with chronic hepatitis B virus infection: a prospective sibling cohort study in Taiwan. J Pediatr 148 (2006) 647-651
27. Yeo W., Zee B., Zhong S., et al. Comprehensive analysis of risk factors associating with hepatitis B virus (HBV) reactivation in cancer patients undergoing cytotoxic chemotherapy. Br J Cancer 90 (2004) 1306-1311
28. Farrell G.C., Joshua D.E., Uren R.F., et al. Androgen-induced hepatoma. The Lancet 1 (1975) 430-432
29. Dai W.S., Kuller L.H., LaPorte R.E., et al. The epidemiology of plasma testosterone levels in middle aged men. Am J Epidemiol 114 (1981) 804-816